Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Catalyst Pharmaceuticals (CPRX) over the last 12 years, with Sep 2025 value amounting to 0.29%.

  • Catalyst Pharmaceuticals' Return on Capital Employed rose 2.00% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year increase of 2.00%. This contributed to the annual value of 0.36% for FY2024, which is 11.00% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.29% for Q3 2025, which was down 0.39% from 0.29% recorded in Q2 2025.
  • Catalyst Pharmaceuticals' Return on Capital Employed's 5-year high stood at 0.37% during Q2 2023, with a 5-year trough of 0.15% in Q2 2024.
  • Moreover, its 3-year median value for Return on Capital Employed was 0.28% (2024), whereas its average is 0.27%.
  • In the last 5 years, Catalyst Pharmaceuticals' Return on Capital Employed dropped by 22bps in 2021 and then rose by 15bps in 2025.
  • Catalyst Pharmaceuticals' Return on Capital Employed (Quarterly) stood at 0.26% in 2021, then grew by 9bps to 0.34% in 2022, then declined by 11bps to 0.24% in 2023, then grew by 4bps to 0.28% in 2024, then increased by 2bps to 0.29% in 2025.
  • Its Return on Capital Employed was 0.29% in Q3 2025, compared to 0.29% in Q2 2025 and 0.30% in Q1 2025.